SC
RPRX icon

Steven Cohen’s Royalty Pharma RPRX Stock Holding History

Steven Cohen’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-123,100
Closed -$4.34M – 4130
2025
Q3 		$4.34M Sell
123,100
-6,000
-5% -$217K 0.01% 1119
2025
Q2 		$4.65M Hold
129,100
– – 0.01% 999
2025
Q1 		$4.02M Buy
+129,100
New +$4.09M 0.01% 1004

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steven Cohen's RPRX Position: Q2 2026 in Review

Steven Cohen reduced its Royalty Pharma (RPRX) stake by 78% in Q2 2026, selling an estimated $20M and leaving 106,549 shares worth $5.97M. The position accounts for 0.01% of the portfolio, ranked #1636.

Steven Cohen first reported a position in RPRX in Q3 2021 and has held it in 13 quarters since. The position peaked at $73.7M in Q1 2022. 640 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Steven Cohen held 106,549 shares of Royalty Pharma worth $5.97M as of Q2 2026.
  • Steven Cohen sold 383,469 Royalty Pharma shares in Q2 2026, an estimated $20M.
  • Royalty Pharma made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1636 holding.
  • Steven Cohen first reported a position in Royalty Pharma in Q3 2021 and has held it in 13 quarters since.
  • Steven Cohen's Royalty Pharma position peaked at $73.7M in Q1 2022.
  • 640 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.